Riffyn VP of Science, Loren Perelman will present at the SIMB 2019 Annual Meeting.
Riffyn will be attending the Next Generation Protein Therapeutics & Bioconjugates Summit in San Francisco, CA June 18-20, 2019.
Riffyn will attend the 2019 AIChE Process Development Symposium in Houston.
Riffyn CEO Timothy Gardner will present at Elemental Machine’s conference Acclerating Science Through Innovation.
Riffyn CEO Timothy Gardner will be speaking at the Commercializing Industrial Biotech Conference in Los Angeles, sponsored by AIChE.
Riffyn CEO Timothy Gardner will be speaking at the Software in the life Sciences conference hosted by Novo Nordisk Center for Biosustainability.
Riffyn CEO, Tim Gardner will be speaking at BPI West, on March 14, 2019 at 10:55 AM in Santa Clara, CA:
Title: Overcoming data silos in process development: batch data to multivariate analysis in 30s
Please visit us at the talk, or contact us to set up a time to meet.
Riffyn will be attending AccBio 2019 in Carlsbad, California from February 17-19. This conference series is dedicated to strategies, technologies and capabilities that accelerate biopharmaceutical development.
Riffyn CEO, Tim Gardner, will present the keynote address on synthetic biology, industrial biotechnology and the transformative impact of digitization of life sciences
Riffyn's Director of Science, Laura Jennings-Antipov, will join fellow panelists Terry Stouch (CSO, Science for Solutions), Ketan Patel (Industry Consultant, Teradata), and Jamie Powers (Sr. Director, Cambridge Semantics), to discuss challenges and recent advancements in data quality, availability, and accessibility. Join us!
Join Riffyn, Amazon Web Services (AWS), and an esteemed panel of thought leaders from GSK, Amyris, Novartis, BASF & DRx Capital for an afternoon/evening of food/cocktails and discussion of machine learning & AI in the life sciences. AWS & Riffyn will provide brief introductions to their toolkits for experiment design, data shaping / integration, and machine learning / AI. This will be followed by a panel discussion of the rapid advance of machine learning & AI in biotech and pharmaceutical R&D. Free and open to anyone (with pre-registration).
Join us at Synbiobeta 2018 for an opening keynote on October 2 by Riffyn CEO, Tim Gardner: Twenty Years of Synthetic Biology: 1998 to 2018.
Join us for presentations on Riffyn SDE by Riffyn's Commercial Director, Doug Williams. Also see use cases with Riffyn SDE presented by Søren Egestad and Katrine Skeby from Novozymes R&D. And we are also hosting a booth. Stop by to say hello and see Riffyn SDE up close!
Want to go from lab data to machine learning in 30 seconds? Join us for the launch of SynBioBetaLive!, a web event we’re premiering on Wednesday, May 23 at 8 am Pacific. Our CEO Timothy Gardner kicks off the inaugural event, to demonstrate and discuss how biological researchers can spend less time organizing their experimental data and more time asking important questions about it.
Today's research and development breakthroughs lie deep in the midst of complex, multivariate data sets. Experimental anomalies and fundamental discoveries often go unnoticed because they are buried in uninterpretable spreadsheets, inaccessible databases, or excessive experimental noise. Riffyn SDE software structures experimental designs and links it to measurement data for machine learning within seconds after it is collected in the lab.
Today's research and development breakthroughs lie deep in the midst of complex, multivariate data sets. Experimental anomalies and fundamental discoveries often go unnoticed because they are buried in uninterpretable spreadsheets, inaccessible databases, or excessive experimental noise. The cloud-based Riffyn SDE software structures experimental designs and links it to measurement data for machine learning within seconds after it is collected in the lab. We will demonstrate how biotech companies are using this capability to identify unexpected correlations in animal studies, uncover root causes of error in screening experiments, and deliver right-first-time technology scale-up in bioprocess development.
Roundtable on Data Science Postsecondary Education Meeting: Reproducibility and Teaching Data Science as a Scientific Process
Tim Gardner will speak at the National Academies of Sciences, Engineering, and Medicine one-day meeting and webcast on "Improving Reproducibility by Teaching Data Science as a Scientific Process". This meeting will bring together data scientists and educators in academia and industry to 1) discuss how data science can help understand and improve reproducibility of scientific research, and 2) learn about several courses and training offerings for reproducible data science.
Be sure to catch Tim Gardner's presentation in Technology Workshop 3: "Laboratory Data to Machine Learning in 30 seconds". In this presentation we will demonstrate how biotech companies are using Riffyn to identify unexpected correlations, uncover root causes of error, and deliver right-first-time technology scale-up.
Join us at Bio-IT World Conference 2017! CEO Tim Gardner will speak as part of the pre-conference workshop, Data Management for Biologics: Registration and Beyond.
Join Tim Gardner from Riffyn at SLAS 2017, where he will chair a session in the Data Analysis and Informatics Track on enhancing scientific reproducibility and reuse through better workflow and data technologies. Drawing from the experiences of speakers in academia, government, and industry, this session emphasizes the use of enhanced workflows, quality management systems, and data utilization to improve experimental rigor and data reproducibility in research and development.
Riffyn CEO Timothy Gardner will present a keynote focused on industrial scale-ups on 15 December 2016 at the first IET /SynbiCITE Conference on Engineering Biology 2016 in London.
Chairman Professor Richard Kitney will welcome engineers, academics and students to the IET/SynBiCITE Engineering Biology Conference 2016 taking place at the newly refurbished IET London: Savoy Place. This three day conference will provide a platform for the international synthetic biology community to hear and present their leading edge research in Synthetic Biology and how these findings are being adopted by industry.